Minifom indications
Topical/Cutaneous
Head pediculosis
Adult: A 4% solution is used for treatment.
Child: >6 mth: A 4% solution is used for treatment.
Topical/Cutaneous
As a skin protectant
Adult: As cream containing Minifom 22% w/w and benzalkonium chloride 0.1% w/w. Apply to the affected area several times a day as needed.
Minifom description
Minifom contains Dimeticone (silicone) 15%, cetyl alcohol (hexadecanol) 5% and glycerol 2%, in a lanolin-free cream base. It also contains methylhydroxybenzoate 0.2% and propylhydroxybenzoate 0.1% as preservatives. It has a pH of 6.
Minifom does not contain perfume, lanolin or lanolin derivatives.
Minifom dosage
Adults: Improvement of Abdominal Symptoms Due to Gas in the Gastrointestinal Tract: 120-240 mg daily divided into 3 times after or between meals by oral route.
Elimination of Foamy Mucus in the Stomach Prior to Gastric Endoscopy: 40-80 mg with about 10 mL of water at 15-40 min prior to the test by oral route.
Elimination of Gas in the Intestine Prior to Abdominal X-Ray Examination: 120-240 mg daily divided into 3 times after or between meals for 3-4 days prior to the test by oral route.
Some adjustments may be made according to the age and symptom of the patient.
Administration: Minifom Drops: Shake and then use.
Minifom interactions
Do not take this product if you are presently taking a prescription antibiotic drug of any form of tetracycline.
The rate and/or extent of absorption of many drugs may be increased or decreased when they are used concurrently with antacids.
Therefore, as a general rule, medication should not be taken within one to two hours of an antacid, if possible.
An incomplete list of substances for which the above statement has been shown to apply includes: tetracycline, iron sans, chlorpromazine, levodopa, isoniazid, digoxin, H2-antagonists, indomethacin, nitrofurantin, and dicumard.
An increase in the plasma level of quinidine and possible toxicity may result if alkalization of the urine occurs during antacid therapy.
Minifom side effects
Adverse reactions were reported in 16 of 2546 patients (0.63%) treated with Minifom. The most frequently observed adverse reactions were soft stools in 8 patients (0.31%), gastric discomfort in 4 patients (0.16%), diarrhea in 3 patients (0.12%) and stomachache in 3 patients (0.12%). No abnormal changes were reported in laboratory tests. (At the end of the re-evaluation.) See Table 2.
Minifom contraindications
Tuberculous, viral lesions of the skin (e.g. herpes simplex and varicella); fungal lesions not susceptible to nystatin, facial rosacea, acne vulgaris or perioral dermatitis. Not to be applied to the external auditory canal in patients with perforated tympanic membranes. Do not use on extensive areas to reduce risk of systemic absorption and neomycin-induced ototoxicity. Not recommended for <1 yr.
Active ingredient matches for Minifom:
Dimeticone in Finland, Iceland, Norway, Sweden.
Dimethicone in Denmark.
Simeticone in Sweden.
| Unit description / dosage (Manufacturer) | Price, USD |
| Capsule; Oral; Dimethicone 1000 188 mg; Silicon Dioxide Colloidal Anhydrous 12 mg | |
| Drops; Oral; Dimethicone 1000 94 mg; Silicon Dioxide Colloidal Anhydrous 6 mg / ml | |
List of Minifom substitutes (brand and generic names): | |
| Metsim (Georgia) | |
| Mintacin | |
| Capsule, Enteric Coated; Oral; Dimethicone 25 mg | |
| MIRADEX | |
| Mirasil DM 20 | |
| Mod's Menzyme (India) | |
| 200ml (ModHike) | $ 0.78 |
| Mod's Menzyme Fungal diastase 50 mg, pepsin10 mg, simeticone 50 mg. SYR / 200ml (ModHike) | $ 0.78 |
| MOD'S MENZYME syr 200ml (ModHike) | $ 0.78 |
| Moisture Barrier | |
| Monistat Complete Care | |
| Mylanta Gas Relief (United States) | |
| Mylicongas (Italy) | |
| Mylom (Thailand) | |
| Mylom 80 80 mg x 100's (Sun Pharma) | |
| Mylom 80 80 mg x 50 x 10's (Sun Pharma) | |
| Mylom Drops 40 mg/0.6 mL x 15 mL (Sun Pharma) | |
| Mylom oral drops 15 mL 15 mL x 1's (Sun Pharma) | |
| Mymus (Portugal) | |
| Nanog (Portugal) | |
| Natural Oatmeal | |
| Nenegax (Colombia) | |
| Neo Dimeticon (Brazil) | |
| Neodrop (Bangladesh) | |
| Neogasol (Chile, Peru) | |
| NEOLANTA (Indonesia) | |
| NEOLANTA 125 mg x 4's | $ 0.10 |
| NEOLANTA 100 mg x 1's | $ 0.03 |
| Neosalus Foam | |
| NeutrapHorus Rex | |
| Nogas (Brazil) | |
| Nogas 400+50 Tablet (Devbhoomi Pharmaceuticals) | $ 0.02 |
| Nogas 200 ml Suspension (Devbhoomi Pharmaceuticals) | $ 0.02 |
| Non-Flat (Peru) | |
| Nopucid Focus (Argentina) | |
| NYDA (Canada, Turkey, United Kingdom) | |
| Nystal (Japan) | |
| Nystal 10% (Japan) | |
| Ofcid | |
| Ofcid 170 ml Syrup (Alcure Pharmaceutical Laboratories (India)) | $ 0.02 |
| Ofcid 170 ml Sanjeevani Biotech Suspension (Alcure Pharmaceutical Laboratories (India)) | $ 0.02 |
| OFCID 300MG SUSPENSION 1 bottle / 170 ML suspension each (Alcure Pharmaceutical Laboratories (India)) | $ 0.57 |
| Ofcid 300mg Suspension (Alcure Pharmaceutical Laboratories (India)) | $ 0.57 |
| Ophtasiloxane (France) | |
| Solution; Ophthalmic; Dimethicone 100% (Alcon) | |
| Orocure (Bangladesh) | |
| Pacquin Plus Hand/Body | |
| Pediacol (Canada) | |
| Drops; Oral; Simethicone 40 mg / ml | |
| Pedicon (Bangladesh) | |
See 732 substitutes for Minifom | |
References
- PubChem. "DIMETHICONE". https://pubchem.ncbi.nlm.nih.gov/sub... (accessed September 17, 2018).
- DrugBank. "Dimethicone - DrugBank". http://www.drugbank.ca/drugs/DB11074 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Minifom are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Minifom. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Minifom drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Not useful | 1 | 100.0% | |
2 consumers reported price estimates
Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?The below mentioned numbers have been reported by ndrugs.com website users about whether the Minifom drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
| Users | % | ||
|---|---|---|---|
| Not expensive | 2 | 100.0% | |
4 consumers reported time for results
To what extent do I have to use Minifom before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 2 days and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Minifom. To get the time effectiveness of using Minifom drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 2 days | 1 | 25.0% | |
| 1 week | 1 | 25.0% | |
| 3 days | 1 | 25.0% | |
| 1 month | 1 | 25.0% | |
17 consumers reported age
| Users | % | ||
|---|---|---|---|
| < 1 | 8 | 47.1% | |
| 1-5 | 2 | 11.8% | |
| 16-29 | 2 | 11.8% | |
| 30-45 | 2 | 11.8% | |
| > 60 | 1 | 5.9% | |
| 46-60 | 1 | 5.9% | |
| 6-15 | 1 | 5.9% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
